Year |
Citation |
Score |
2021 |
Jacobs HIL, Becker JA, Kwong K, Engels-Domínguez N, Prokopiou PC, Papp KV, Properzi M, Hampton OL, d'Oleire Uquillas F, Sanchez JS, Rentz DM, El Fakhri G, Normandin MD, Price JC, Bennett DA, ... Sperling RA, et al. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline. Science Translational Medicine. 13: eabj2511. PMID 34550726 DOI: 10.1126/scitranslmed.abj2511 |
0.339 |
|
2021 |
Ngolab J, Donohue M, Belsha A, Salazar J, Cohen P, Jaiswal S, Tan V, Gessert D, Korouri S, Aggarwal NT, Alber J, Johnson K, Jicha G, van Dyck C, Lah J, ... ... Sperling RA, et al. Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12199. PMID 34430703 DOI: 10.1002/dad2.12199 |
0.303 |
|
2021 |
Mayblyum DV, Becker JA, Jacobs HIL, Buckley RF, Schultz AP, Sepulcre J, Sanchez JS, Rubinstein ZB, Katz SR, Moody KA, Vannini P, Papp KV, Rentz DM, Price JC, Sperling RA, et al. Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease. Neurology. PMID 33952655 DOI: 10.1212/WNL.0000000000012108 |
0.305 |
|
2021 |
Belloy ME, Eger SJ, Le Guen Y, Napolioni V, Deters KD, Yang HS, Scelsi MA, Porter T, James SN, Wong A, Schott JM, Sperling RA, Laws SM, Mormino EC, He Z, et al. KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers. Neurobiology of Aging. 101: 123-129. PMID 33610961 DOI: 10.1016/j.neurobiolaging.2021.01.008 |
0.329 |
|
2021 |
Guzmán-Vélez E, Zetterberg H, Fox-Fuller JT, Vila-Castelar C, Sanchez JS, Baena A, Garcia-Ospina G, Aguillon D, Pardilla-Delgado E, Gatchel JR, Sperling RA, Johnson K, Reiman EM, Blennow K, Lopera F, et al. Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33527648 DOI: 10.1002/alz.12248 |
0.351 |
|
2021 |
Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, Properzi MJ, Katz SR, Beiser A, Satizabal CL, O'Donnell A, DeCarli C, Killiany R, El Fakhri G, Normandin MD, ... ... Sperling RA, et al. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography. Science Translational Medicine. 13. PMID 33472953 DOI: 10.1126/scitranslmed.abc0655 |
0.36 |
|
2021 |
Sanchez JS, Hanseeuw BJ, Lopera F, Sperling RA, Baena A, Bocanegra Y, Aguillon D, Guzmán-Vélez E, Pardilla-Delgado E, Ramirez-Gomez L, Vila-Castelar C, Martinez JE, Fox-Fuller JT, Ramos C, Ochoa-Escudero M, et al. Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study. Alzheimer's Research & Therapy. 13: 27. PMID 33451357 DOI: 10.1186/s13195-020-00765-5 |
0.358 |
|
2021 |
Papp KV, Rentz DM, Maruff P, Sun CK, Raman R, Donohue MC, Schembri A, Stark C, Yassa MA, Wessels AM, Yaari R, Holdridge KC, Aisen PS, Sperling RA. The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial. The Journal of Prevention of Alzheimer's Disease. 8: 59-67. PMID 33336226 DOI: 10.14283/jpad.2020.38 |
0.357 |
|
2020 |
Samaroo A, Amariglio RE, Burnham S, Sparks P, Properzi M, Schultz AP, Buckley R, Johnson KA, Sperling RA, Rentz DM, Papp KV. Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12132. PMID 33426266 DOI: 10.1002/dad2.12132 |
0.311 |
|
2020 |
Chhatwal JP, Schultz AP, Dang Y, Ostaszewski B, Liu L, Yang HS, Johnson KA, Sperling RA, Selkoe DJ. Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals. Nature Communications. 11: 6024. PMID 33247134 DOI: 10.1038/s41467-020-19543-w |
0.343 |
|
2020 |
Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, et al. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology. PMID 33199430 DOI: 10.1212/WNL.0000000000011214 |
0.307 |
|
2020 |
Dubbelman MA, Jutten RJ, Tomaszewski Farias SE, Amariglio RE, Buckley RF, Visser PJ, Rentz DM, Johnson KA, Properzi MJ, Schultz A, Donovan N, Gatchell JR, Teunissen CE, Van Berckel BNM, Van der Flier WM, ... Sperling RA, et al. Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuum. Alzheimer's Research & Therapy. 12: 138. PMID 33121534 DOI: 10.1186/s13195-020-00706-2 |
0.374 |
|
2020 |
Jutten RJ, Sikkes SAM, Amariglio RE, Buckley RF, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Teunissen CE, Van Berckel BNM, Van der Flier WM, Scheltens P, Sperling RA, Papp KV, et al. Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's Disease. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 33046162 DOI: 10.1017/S1355617720000934 |
0.375 |
|
2020 |
Hampton OL, Buckley RF, Manning LK, Scott MR, Properzi MJ, Peña-Gómez C, Jacobs HIL, Chhatwal JP, Johnson KA, Sperling RA, Schultz AP. Resting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer's disease. Neuroimage. Clinical. 28: 102407. PMID 32942175 DOI: 10.1016/J.Nicl.2020.102407 |
0.304 |
|
2020 |
Walter S, Langford OG, Clanton TB, Jimenez-Maggiora GA, Raman R, Rafii MS, Shaffer EJ, Sperling RA, Cummings JL, Aisen PS. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years. The Journal of Prevention of Alzheimer's Disease. 7: 234-241. PMID 32920625 DOI: 10.14283/jpad.2020.47 |
0.326 |
|
2020 |
Aisen PS, Sperling RA, Cummings J, Donohue MC, Langford O, Jimenez-Maggiora GA, Rissman RA, Rafii MS, Walter S, Clanton T, Raman R. The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview. The Journal of Prevention of Alzheimer's Disease. 7: 208-212. PMID 32920621 DOI: 10.14283/jpad.2020.45 |
0.324 |
|
2020 |
Vila-Castelar C, Muñoz N, Papp KV, Amariglio RE, Baena A, Guzmán-Vélez E, Bocanegra Y, Sanchez JS, Reiman EM, Johnson KA, Sperling RA, Lopera F, Rentz DM, Quiroz YT. The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 12: 104. PMID 32912283 DOI: 10.1186/s13195-020-00671-w |
0.339 |
|
2020 |
Dumitrescu L, Mahoney ER, Mukherjee S, Lee ML, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski C, Hernandez Saucedo H, Widaman KF, Buckley R, Properzi M, ... ... Sperling RA, et al. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain : a Journal of Neurology. 143: 2561-2575. PMID 32844198 DOI: 10.1093/Brain/Awaa209 |
0.32 |
|
2020 |
Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J. Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. Jama Neurology. PMID 32777010 DOI: 10.1001/Jamaneurol.2020.2734 |
0.338 |
|
2020 |
Scott MR, Hampton OL, Buckley RF, Chhatwal JP, Hanseeuw BJ, Jacobs HIL, Properzi MJ, Sanchez JS, Johnson KA, Sperling RA, Schultz AP. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults. Neuroimage. 116991. PMID 32512123 DOI: 10.1016/J.Neuroimage.2020.116991 |
0.325 |
|
2020 |
Insel PS, Donohue MC, Sperling R, Hansson O, Mattsson-Carlgren N. The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults. Annals of Clinical and Translational Neurology. PMID 32315118 DOI: 10.1002/Acn3.51048 |
0.316 |
|
2020 |
Jacobs HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, Locascio J, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA. The presubiculum links incipient amyloid and tau pathology to memory function in older persons. Neurology. PMID 32273431 DOI: 10.1212/WNL.0000000000009362 |
0.333 |
|
2020 |
Rabin JS, Shirzadi Z, Swardfager W, MacIntosh BJ, Schultz A, Yang HS, Buckley RF, Gatchel JR, Kirn D, Pruzin JJ, Hedden T, Lipsman N, Rentz DM, Black SE, Johnson KA, ... Sperling RA, et al. Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults. Neurobiology of Aging. PMID 32249013 DOI: 10.1016/J.Neurobiolaging.2020.03.002 |
0.331 |
|
2020 |
Biddle KD, Jacobs HIL, d'Oleire Uquillas F, Zide BS, Kirn DR, Properzi MR, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults. Jama Network Open. 3: e200121. PMID 32101313 DOI: 10.1001/jamanetworkopen.2020.0121 |
0.328 |
|
2020 |
Putcha D, Dickerson BC, Brickhouse M, Johnson KA, Sperling RA, Papp KV. Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum. Neuropsychologia. 107391. PMID 32057937 DOI: 10.1016/j.neuropsychologia.2020.107391 |
0.32 |
|
2020 |
Vila-Castelar C, Muñoz N, Papp K, Amariglio R, Baena A, Guzmán-Vélez E, Bocanegra Y, Reiman E, Johnson K, Sperling R, Lopera F, Rentz D, Quiroz Y. A-05 The Latin American Spanish Version of the Face-Name Associative Memory Exam is Sensitive to Cognitive and Pathological Changes in Preclinical Autosomal Dominant Alzheimer’s Disease Archives of Clinical Neuropsychology. 35: 778-778. DOI: 10.1093/arclin/acaa067.05 |
0.34 |
|
2020 |
Davidow J, Biddle K, Johnson K, Sperling R, Donovan N. INTERACTIVE ASSOCIATION OF LIVING ALONE AND AMYLOID-Β BURDEN WITH LONGITUDINAL COGNITION IN COGNITIVELY UNIMPAIRED OLDER ADULTS The American Journal of Geriatric Psychiatry. 28: S76. DOI: 10.1016/J.Jagp.2020.01.102 |
0.348 |
|
2020 |
Farrell ME, Papp KV, Jacobs HI, Buckley RF, Properzi MJ, Schultz AP, Hanseeuw B, Rentz DM, Johnson KA, Sperling RA. Distinct contributions of longitudinal tau and amyloid to decline in various cognitive domains in preclinical AD Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046075 |
0.335 |
|
2020 |
Buckley RF, Chou HL, Properzi MJ, Papp KV, Chhatwal JP, Rentz D, Johnson KA, Sperling RA, Schultz AP. Are amyloid and tau synergistic? How to interpret an amyloid/tau interaction on cognitive decline in clinically normal adults Alzheimer's & Dementia. 16. DOI: 10.1002/alz.044310 |
0.327 |
|
2019 |
Gatchel JR, Lopera F, Norton DJ, Baena A, Guzman-Velez E, Sanchez JS, d'Oleire Uquillas F, Schultz A, Vannini P, Artola A, Amariglio RE, Rentz DM, Tariot PN, Reiman EM, Johnson KA, ... Sperling RA, et al. Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31874859 DOI: 10.1136/Jnnp-2019-321205 |
0.399 |
|
2019 |
Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nature Reviews. Neurology. PMID 31827267 DOI: 10.1038/S41582-019-0281-2 |
0.303 |
|
2019 |
Jack CR, Holtzman DM, Sperling R. Dementia is not synonymous with Alzheimer's disease. Science Translational Medicine. 11. PMID 31826979 DOI: 10.1126/Scitranslmed.Aav0511 |
0.316 |
|
2019 |
Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31759879 DOI: 10.1016/J.Jalz.2019.09.074 |
0.375 |
|
2019 |
d'Oleire Uquillas F, Jacobs HIL, Schultz AP, Hanseeuw BJ, Buckley RF, Sepulcre J, Pascual-Leone A, Donovan NJ, Johnson KA, Sperling RA, Vannini P. Functional and Pathological Correlates of Judgments of Learning in Cognitively Unimpaired Older Adults. Cerebral Cortex (New York, N.Y. : 1991). PMID 31696223 DOI: 10.1093/cercor/bhz217 |
0.331 |
|
2019 |
Arboleda-Velasquez JF, Lopera F, O'Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, Leyton-Cifuentes D, Chen K, Baena A, Aguillon D, Rios-Romenets S, et al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nature Medicine. PMID 31686034 DOI: 10.1038/S41591-019-0611-3 |
0.338 |
|
2019 |
Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 670-678. PMID 31673597 DOI: 10.1016/j.dadm.2019.08.004 |
0.317 |
|
2019 |
Rabin JS, Klein H, Kirn DR, Schultz AP, Yang HS, Hampton O, Jiang S, Buckley RF, Viswanathan A, Hedden T, Pruzin J, Yau WW, Guzmán-Vélez E, Quiroz YT, Properzi M, ... ... Sperling RA, et al. Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults. Jama Neurology. PMID 31312836 DOI: 10.1001/Jamaneurol.2019.1879 |
0.341 |
|
2019 |
Biddle KD, Uquillas FD, Jacobs HIL, Zide B, Kirn DR, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31248770 DOI: 10.1016/j.jagp.2019.05.005 |
0.327 |
|
2019 |
Rabin JS, Perea RD, Buckley RF, Johnson KA, Sperling RA, Hedden T. Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults. Neurobiology of Aging. 81: 38-46. PMID 31207468 DOI: 10.1016/j.neurobiolaging.2019.05.005 |
0.324 |
|
2019 |
Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, ... ... Sperling RA, et al. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. Jama Neurology. PMID 31157827 DOI: 10.1001/Jamaneurol.2019.1424 |
0.374 |
|
2019 |
Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, ... ... Sperling RA, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain : a Journal of Neurology. PMID 31039256 DOI: 10.1093/Brain/Awz099 |
0.32 |
|
2019 |
Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, ... Sperling RA, et al. Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred. The Journal of Prevention of Alzheimer's Disease. 6: 112-120. PMID 30756118 DOI: 10.14283/jpad.2019.6 |
0.359 |
|
2019 |
Hanseeuw BJ, Lopera F, Sperling RA, Norton DJ, Guzman-Velez E, Baena A, Pardilla-Delgado E, Schultz AP, Gatchel J, Jin D, Chen K, Reiman EM, Johnson KA, Quiroz YT. Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease. Alzheimer's Research & Therapy. 11: 17. PMID 30717814 DOI: 10.1186/S13195-019-0468-1 |
0.316 |
|
2019 |
Halawa OA, Gatchel JR, Amariglio RE, Rentz DM, Sperling RA, Johnson KA, Marshall GA. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. Alzheimer's Research & Therapy. 11: 14. PMID 30704519 DOI: 10.1186/s13195-019-0471-6 |
0.396 |
|
2019 |
Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL, Yaffe K, Schellenberg GD, Kauppi K, Holland D, McEvoy LK, ... ... Sperling RA, et al. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration. Brain : a Journal of Neurology. PMID 30689776 DOI: 10.1093/Brain/Awy327 |
0.356 |
|
2019 |
Marshall GA, Gatchel JR, Donovan NJ, Muniz MC, Schultz AP, Becker JA, Chhatwal JP, Hanseeuw BJ, Papp KV, Amariglio RE, Rentz DM, Sperling RA, Johnson KA. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia. Journal of Alzheimer's Disease : Jad. 67: 757-768. PMID 30689584 DOI: 10.3233/Jad-170578 |
0.384 |
|
2019 |
Jagust W, Jack CR, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, ... ... Sperling R, et al. "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 15: 153-157. PMID 30642435 DOI: 10.1016/J.Jalz.2018.11.002 |
0.306 |
|
2019 |
Yang H, Ge T, Finucane H, De Jager PL, Sperling RA. P4-496: MYELOID CELL-SPECIFIC ALZHEIMER'S DISEASE POLYGENIC RISK SCORE PREDICTS NEURODEGENERATION AND Aβ-RELATED COGNITIVE DECLINE IN COGNITIVELY NORMAL OLDER ADULTS Alzheimer's & Dementia. 15: P1503-P1504. DOI: 10.1016/j.jalz.2019.08.042 |
0.35 |
|
2019 |
Papp KV, Buckley RF, Mormino EC, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz D, Sperling RA, Amariglio R. F2-03-01: CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID Alzheimer's & Dementia. 15: P518-P519. DOI: 10.1016/j.jalz.2019.06.4424 |
0.315 |
|
2019 |
Sikkes SA, Gatchel JR, Buckley RF, van de Wiel MA, Rentz DM, Johnson KA, Sperling RA, Amariglio R. P4-353: SPECIFIC FEATURES OF SUBJECTIVE COGNITIVE DECLINE ARE RELATED TO AMYLOID AND TAU PATHOLOGY IN COGNITIVELY HEALTHY OLDER ADULTS Alzheimer's & Dementia. 15: P1433-P1434. DOI: 10.1016/j.jalz.2019.06.4024 |
0.32 |
|
2019 |
Papp KV, Buckley RF, Mormino EC, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio R. P3-031: CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID Alzheimer's & Dementia. 15: P937-P938. DOI: 10.1016/J.Jalz.2019.06.3057 |
0.327 |
|
2019 |
Jacobs HI, Becker A, Sperling RA, Guzman-Velez E, Baena A, Uquillas Fd, Artola A, Pardilla-Delgado E, Gatchel JR, Reiman EM, Johnson KA, Lopera F, Quiroz YT. P2-425: LOCUS COERULEUS INTENSITY IS ASSOCIATED WITH EARLY AMYLOID AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P774-P775. DOI: 10.1016/J.Jalz.2019.06.2832 |
0.317 |
|
2018 |
Rabin JS, Yang HS, Schultz AP, Hanseeuw BJ, Hedden T, Viswanathan A, Gatchel JR, Marshall GA, Kilpatrick E, Klein H, Rao V, Buckley RF, Yau WW, Kirn DR, Rentz DM, ... ... Sperling RA, et al. Vascular risk and β-amyloid are synergistically associated with cortical tau. Annals of Neurology. PMID 30565287 DOI: 10.1002/Ana.25399 |
0.325 |
|
2018 |
d'Oleire Uquillas F, Jacobs HIL, Biddle KD, Properzi M, Hanseeuw B, Schultz AP, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Regional tau pathology and loneliness in cognitively normal older adults. Translational Psychiatry. 8: 282. PMID 30563962 DOI: 10.1038/s41398-018-0345-x |
0.374 |
|
2018 |
Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T, Marshall GA, Quiroz YT, Donovan NJ, Jackson J, Gatchel JR, et al. The impact of Aβ and tau on prospective cognitive decline in older individuals. Annals of Neurology. PMID 30549303 DOI: 10.1002/Ana.25395 |
0.399 |
|
2018 |
Huijbers W, Schultz AP, Papp KV, LaPoint MR, Hanseeuw B, Chhatwal JP, Hedden T, Johnson KA, Sperling RA. Tau accumulation in clinically normal older adults is associated with hippocampal hyperactivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30482786 DOI: 10.1523/Jneurosci.1397-18.2018 |
0.363 |
|
2018 |
McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, ... ... Sperling RA, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277 |
0.341 |
|
2018 |
Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Molecular Psychiatry. PMID 30116029 DOI: 10.1038/s41380-018-0214-2 |
0.302 |
|
2018 |
Guzmán-Vélez E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, Papp KV, Amariglio R, Rentz D, Baena A, Henao E, Tirado V, Muñoz C, Giraldo M, Sperling RA, Lopera F, Quiroz YT. A Three-Factor Structure of Cognitive Functioning Among Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30040714 DOI: 10.1093/Arclin/Acw043.34 |
0.36 |
|
2018 |
Munro CE, Donovan NJ, Amariglio RE, Papp KV, Marshall GA, Rentz DM, Pascual-Leone A, Sperling RA, Locascio JJ, Vannini P. The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 29866588 DOI: 10.1016/j.jagp.2018.04.008 |
0.375 |
|
2018 |
Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, ... ... Sperling RA, et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29803541 DOI: 10.1016/J.Jalz.2018.04.010 |
0.344 |
|
2018 |
Rabin JS, Schultz AP, Hedden T, Viswanathan A, Marshall GA, Kilpatrick E, Klein H, Buckley RF, Yang HS, Properzi M, Rao V, Kirn DR, Papp KV, Rentz DM, Johnson KA, ... Sperling RA, et al. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study. Jama Neurology. PMID 29799986 DOI: 10.1001/Jamaneurol.2018.1123 |
0.344 |
|
2018 |
Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, ... ... Sperling R, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 535-562. PMID 29653606 DOI: 10.1016/J.Jalz.2018.02.018 |
0.375 |
|
2018 |
Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino EC. Dissociable influences ofε4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. PMID 29592889 DOI: 10.1212/Wnl.0000000000005415 |
0.339 |
|
2018 |
Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Sperling RA, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053 |
0.305 |
|
2018 |
Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, et al. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. Jama Neurology. PMID 29435558 DOI: 10.1001/Jamaneurol.2017.4907 |
0.342 |
|
2018 |
Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA. Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nature Neuroscience. PMID 29403032 DOI: 10.1038/s41593-018-0070-z |
0.328 |
|
2018 |
d'Oleire Uquillas F, Jacobs HIL, Hanseeuw B, Marshall GA, Properzi M, Schultz AP, LaPoint MR, Johnson KA, Sperling RA, Vannini P. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals. Neuroimage. Clinical. 17: 388-396. PMID 29159051 DOI: 10.1016/j.nicl.2017.10.034 |
0.365 |
|
2018 |
Uquillas Fd, Jacobs HIL, Hanseeuw BJ, Sikkes SAM, Marshall GA, Pascual-Leone A, Johnson KA, Sperling RA, Vannini P. P3-290: Amyloid Pathology Explains Unawareness Of Memory Deficits Above And Beyond Cortical Thickness In Individuals With Mild Cognitive Impairment Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1650 |
0.303 |
|
2017 |
Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5. Alzheimer's & Dementia (New York, N. Y.). 3: 668-677. PMID 29264389 DOI: 10.1016/j.trci.2017.10.004 |
0.349 |
|
2017 |
Buckley RF, Sparks KP, Papp KV, Dekhtyar M, Martin C, Burnham S, Sperling RA, Rentz DM. Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries. The Journal of Prevention of Alzheimer's Disease. 4: 3-11. PMID 29188853 DOI: 10.14283/jpad.2017.1 |
0.33 |
|
2017 |
Jackson JD, Rentz DM, Aghjayan SL, Buckley RF, Meneide TF, Sperling RA, Amariglio RE. Subjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons. Age and Ageing. 46: 988-993. PMID 29088363 DOI: 10.1093/ageing/afx077 |
0.337 |
|
2017 |
Dumurgier J, Hanseeuw BJ, Hatling FB, Judge KA, Schultz AP, Chhatwal JP, Blacker D, Sperling RA, Johnson KA, Hyman BT, Gómez-Isla T. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 29036824 DOI: 10.3233/Jad-170511 |
0.358 |
|
2017 |
Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio RE. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. Jama Neurology. PMID 28973551 DOI: 10.1001/jamaneurol.2017.2216 |
0.372 |
|
2017 |
Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, Papp KV, Amariglio RE, Rentz DM, Blacker D, Sperling RA, Johnson KA, Marshall GA. Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 28697559 DOI: 10.3233/Jad-170001 |
0.303 |
|
2017 |
Vannini P, Hanseeuw B, Munro CE, Amariglio RE, Marshall GA, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RA. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Neuroimage. Clinical. 15: 408-414. PMID 28616381 DOI: 10.1016/j.nicl.2017.05.020 |
0.316 |
|
2017 |
Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons. Jama. 317: 2305-2316. PMID 28609533 DOI: 10.1001/Jama.2017.6669 |
0.313 |
|
2017 |
Buckley RF, Schultz AP, Hedden T, Papp KV, Hanseeuw BJ, Marshall G, Sepulcre J, Smith EE, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Functional network integrity presages cognitive decline in preclinical Alzheimer disease. Neurology. PMID 28592457 DOI: 10.1212/Wnl.0000000000004059 |
0.333 |
|
2017 |
Sepulcre J, Grothe MJ, Sabuncu M, Chhatwal J, Schultz AP, Hanseeuw B, El Fakhri G, Sperling R, Johnson KA. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex. Jama Neurology. PMID 28558094 DOI: 10.1001/Jamaneurol.2017.0263 |
0.309 |
|
2017 |
Gatchel JR, Donovan NJ, Locascio JJ, Becker JA, Rentz DM, Sperling RA, Johnson KA, Marshall GA. Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 28410856 DOI: 10.1016/j.jagp.2016.12.017 |
0.384 |
|
2017 |
Vannini P, Amariglio R, Hanseeuw B, Johnson KA, McLaren DG, Chhatwal J, Pascual-Leone A, Rentz D, Sperling RA. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease. Neuropsychologia. PMID 28385579 DOI: 10.1016/J.Neuropsychologia.2017.04.002 |
0.338 |
|
2017 |
Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, Huijbers W, LaPoint M, Buckley RF, Johnson KA, Sperling RA. Phases of hyper and hypo connectivity in the Default Mode and Salience networks track with amyloid and Tau in clinically normal individuals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28314821 DOI: 10.1523/Jneurosci.3263-16.2017 |
0.315 |
|
2017 |
Papp KV, Rentz DM, Mormino EC, Schultz AP, Amariglio RE, Quiroz Y, Johnson KA, Sperling RA. Cued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology. PMID 28283594 DOI: 10.1212/Wnl.0000000000003812 |
0.319 |
|
2017 |
Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, ... Sperling RA, et al. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated β-amyloid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28253478 DOI: 10.1016/J.Jalz.2017.01.018 |
0.36 |
|
2017 |
Yang H, Yu L, White CC, Sperling RA, Bennett DA, Schneider JA, De Jager PL. [P2-115]: A TMEM106B
LOCUS IS IMPLICATED IN COGNITIVE DECLINE IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P650-P651. DOI: 10.1016/J.Jalz.2017.06.765 |
0.347 |
|
2017 |
Gatchel JR, Norton D, Baena A, Guzman-Velez E, Lopera F, Johnson K, Sperling RA, Marshall GA, Quiroz YT. [IC-P-089]: ANXIETY, SUBJECTIVE COGNITIVE DECLINE, AND CORTICAL AMYLOID IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER's DISEASE: A PRELIMINARY REPORT Alzheimer's & Dementia. 13: P72-P72. DOI: 10.1016/j.jalz.2017.06.2362 |
0.337 |
|
2017 |
Reiman EM, Kuang X, Luo J, Chen Y, Thiyyagura P, Bauer R, Lee W, Protas H, Goradia DD, Aisen PS, Johnson K, Langbaum JB, Sperling RA, Tariot P, Jagust WJ, et al. [IC-P-041]: SAMPLE SIZES FOR 24-MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS Alzheimer's & Dementia. 13: P36-P37. DOI: 10.1016/J.Jalz.2017.06.2313 |
0.303 |
|
2017 |
Gatchel JR, Norton DJ, Baena A, Guzman-Velez E, Lopera F, Johnson K, Sperling RA, Marshall GA, Quiroz YT. [P4-243]: ANXIETY, SUBJECTIVE COGNITIVE DECLINE, AND CORTICAL AMYLOID IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER's DISEASE: A PRELIMINARY REPORT Alzheimer's & Dementia. 13: P1369-P1370. DOI: 10.1016/J.Jalz.2017.06.2111 |
0.359 |
|
2016 |
Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, Ewers M, Hampel H, Klöppel S, Rami L, Reisberg B, Saykin AJ, Sikkes S, Smart CM, Snitz BE, ... Sperling R, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27825022 DOI: 10.1016/J.Jalz.2016.09.012 |
0.342 |
|
2016 |
Donovan NJ, Okereke OI, Vannini P, Amariglio RE, Rentz DM, Marshall GA, Johnson KA, Sperling RA. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. Jama Psychiatry. PMID 27806159 DOI: 10.1001/jamapsychiatry.2016.2657 |
0.373 |
|
2016 |
Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KA. Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance. Brain Imaging and Behavior. PMID 27738998 DOI: 10.1007/s11682-016-9640-4 |
0.343 |
|
2016 |
Aghjayan SL, Buckley RF, Vannini P, Rentz DM, Jackson JD, Sperling RA, Johnson KA, Amariglio RE. The influence of demographic factors on subjective cognitive concerns and beta-amyloid. International Psychogeriatrics. 1-8. PMID 27724996 DOI: 10.1017/S1041610216001502 |
0.369 |
|
2016 |
Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT. Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 27702899 DOI: 10.1073/Pnas.1611073113 |
0.315 |
|
2016 |
Albers AD, Asafu-Adjei J, Delaney MK, Kelly KE, Gomez-Isla T, Blacker D, Johnson KA, Sperling RA, Hyman BT, Betensky RA, Hastings L, Albers MW. Episodic Memory of Odors Stratifies Alzheimer Biomarkers in Normal Elderly. Annals of Neurology. PMID 27696605 DOI: 10.1002/Ana.24792 |
0.343 |
|
2016 |
Mormino EC, Papp KV, Rentz DM, Schultz AP, LaPoint M, Amariglio R, Hanseeuw B, Marshall GA, Hedden T, Johnson KA, Sperling RA. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. Jama Neurology. PMID 27548655 DOI: 10.1001/jamaneurol.2016.2237 |
0.311 |
|
2016 |
Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio R. A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease. Journal of Molecular Neuroscience : Mn. PMID 27514526 DOI: 10.1007/S12031-016-0810-Z |
0.367 |
|
2016 |
Hanseeuw BJ, Schultz AP, Betensky RA, Sperling RA, Johnson KA. Decreased hippocampal metabolism in high-amyloid mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27421609 DOI: 10.1016/j.jalz.2016.06.2357 |
0.328 |
|
2016 |
Fotiadis P, van Rooden S, van der Grond J, Schultz A, Martinez-Ramirez S, Auriel E, Reijmer Y, van Opstal AM, Ayres A, Schwab KM, Alzheimer's Disease Neuroimaging Initiative Adni, Hedden T, Rosand J, Viswanathan A, Wermer M, ... ... Sperling RA, et al. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. The Lancet. Neurology. PMID 27180034 DOI: 10.1016/S1474-4422(16)30030-8 |
0.321 |
|
2016 |
Rieckmann A, Van Dijk KR, Sperling RA, Johnson KA, Buckner RL, Hedden T. Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's disease. Neurobiology of Aging. 42: 177-88. PMID 27143434 DOI: 10.1016/j.neurobiolaging.2016.03.016 |
0.319 |
|
2016 |
Rabinovici GD, Karlawish J, Knopman D, Snyder HM, Sperling R, Carrillo MC. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 12: 510-5. PMID 27103054 DOI: 10.1016/J.Jalz.2016.03.002 |
0.342 |
|
2016 |
Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... Sperling RA, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647 |
0.305 |
|
2016 |
Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ. Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nature Reviews. Neurology. PMID 26782335 DOI: 10.1038/Nrneurol.2015.251 |
0.335 |
|
2016 |
Buckley RF, Hanseeuw BJ, Vannini P, Rentz DM, Sperling RA, Johnson K, Amariglio R. TAU BURDEN IS ASSOCIATED WITH SUBJECTIVE COGNITIVE CONCERNS IN THE CONTEXT OF β-AMYLOID BURDEN IN PRECLINICAL AD Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.07.069 |
0.337 |
|
2015 |
Marshall GA, Dekhtyar M, Bruno JM, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM. The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. The Journal of Prevention of Alzheimer's Disease. 2: 242-253. PMID 26665121 DOI: 10.14283/jpad.2015.72 |
0.348 |
|
2015 |
Malishkevich A, Marshall GA, Schultz AP, Sperling RA, Aharon-Peretz J, Gozes I. Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 26639975 DOI: 10.3233/JAD-150799 |
0.369 |
|
2015 |
Papp KV, Mormino EC, Amariglio RE, Munro C, Dagley A, Schultz AP, Johnson KA, Sperling RA, Rentz DM. Biomarker Validation of a Decline in Semantic Processing in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26595826 DOI: 10.1037/neu0000246 |
0.346 |
|
2015 |
Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, ... ... Sperling R, et al. Tau PET imaging in aging and early Alzheimer's disease. Annals of Neurology. PMID 26505746 DOI: 10.1002/Ana.24546 |
0.308 |
|
2015 |
Guercio BJ, Donovan NJ, Munro CE, Aghjayan SL, Wigman SE, Locascio JJ, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 47: 421-32. PMID 26401564 DOI: 10.3233/JAD-150146 |
0.357 |
|
2015 |
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... Sperling R, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903 |
0.33 |
|
2015 |
Gidicsin CM, Maye JE, Locascio JJ, Pepin LC, Philiossaint M, Becker JA, Younger AP, Dekhtyar M, Schultz AP, Amariglio RE, Marshall GA, Rentz DM, Hedden T, Sperling RA, Johnson KA. Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers. Neurology. 85: 48-55. PMID 26062627 DOI: 10.1212/Wnl.0000000000001704 |
0.338 |
|
2015 |
Marshall GA, Zoller AS, Lorius N, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DM, For The Alzheimer's Disease Neuroimaging Initiative EY. Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment. Current Alzheimer Research. 12: 493-502. PMID 26017560 |
0.366 |
|
2015 |
Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DM. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease. Neuropsychologia. 73: 169-75. PMID 26002757 DOI: 10.1016/j.neuropsychologia.2015.04.034 |
0.344 |
|
2015 |
Munro CE, Donovan NJ, Guercio BJ, Wigman SE, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 25854929 DOI: 10.3233/JAD-150017 |
0.334 |
|
2015 |
Guercio BJ, Donovan NJ, Ward A, Schultz A, Lorius N, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. The Journal of Neuropsychiatry and Clinical Neurosciences. 27: e22-7. PMID 25716491 DOI: 10.1176/appi.neuropsych.13060141 |
0.329 |
|
2015 |
Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument. Jama Neurology. 72: 446-54. PMID 25706191 DOI: 10.1001/Jamaneurol.2014.3375 |
0.376 |
|
2015 |
Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, Okereke OI, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 25697700 DOI: 10.3233/JAD-142940 |
0.304 |
|
2015 |
Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, Amariglio RE, Marshall GA, Rentz DM, Johnson KA, Sperling RA. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain : a Journal of Neurology. 138: 1023-35. PMID 25678559 DOI: 10.1093/Brain/Awv007 |
0.331 |
|
2015 |
Replogle JM, Chan G, White CC, Raj T, Winn PA, Evans DA, Sperling RA, Chibnik LB, Bradshaw EM, Schneider JA, Bennett DA, De Jager PL. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Annals of Neurology. 77: 469-77. PMID 25545807 DOI: 10.1002/Ana.24337 |
0.33 |
|
2015 |
Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, Marshall GA. Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Disease and Associated Disorders. 29: 18-25. PMID 24787033 DOI: 10.1097/WAD.0000000000000043 |
0.354 |
|
2015 |
Hanseeuw BJ, Schultz AP, Sperling RA, Johnson KA. P4-083: Hippocampal metabolism is decreased in high-amyloid mild cognitive impairment but not in high-amyloid clinically normal elders Alzheimer's & Dementia. 11: P802-P803. DOI: 10.1016/j.jalz.2015.06.1788 |
0.305 |
|
2014 |
Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack CR, Sperling R, Cummings J, Blennow K, O'Bryant S, Frisoni GB, Khachaturian A, Kivipelto M, Klunk W, et al. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. The Journal of Prevention of Alzheimer's Disease. 1: 181-202. PMID 26478889 DOI: 10.14283/jpad.2014.32 |
0.347 |
|
2014 |
Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron. 84: 608-22. PMID 25442939 DOI: 10.1016/J.Neuron.2014.10.038 |
0.365 |
|
2014 |
Marshall GA, Zoller AS, Kelly KE, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DM, For The Alzheimer's Disease Neuroimaging Initiative. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Current Alzheimer Research. 11: 853-61. PMID 25274110 |
0.329 |
|
2014 |
Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. Jama Neurology. 71: 1379-85. PMID 25222039 DOI: 10.1001/jamaneurol.2014.2031 |
0.318 |
|
2014 |
Zoller AS, Gaal IM, Royer CA, Locascio JJ, Amariglio RE, Blacker D, Okereke OI, Johnson KA, Sperling RA, Rentz DM, Marshall GA. SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Current Alzheimer Research. 11: 785-91. PMID 25212917 DOI: 10.2174/156720501108140910122220 |
0.358 |
|
2014 |
Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GA. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum. Journal of Alzheimer's Disease : Jad. 42: 291-300. PMID 24898635 DOI: 10.3233/JAD-131796 |
0.353 |
|
2014 |
Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, Weiner M, Aisen PS. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. Jama Neurology. 71: 961-70. PMID 24886908 DOI: 10.1001/Jamaneurol.2014.803 |
0.337 |
|
2014 |
Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, Sherman J, Sperling RA, Rentz DM. Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory. The Clinical Neuropsychologist. 28: 771-85. PMID 24815535 DOI: 10.1080/13854046.2014.911351 |
0.322 |
|
2014 |
Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, ... ... Sperling RA, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 844-52. PMID 24798886 DOI: 10.1016/J.Jalz.2014.01.001 |
0.347 |
|
2014 |
Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology. 82: 1760-7. PMID 24748674 DOI: 10.1212/Wnl.0000000000000431 |
0.338 |
|
2014 |
Huijbers W, Mormino EC, Wigman SE, Ward AM, Vannini P, McLaren DG, Becker JA, Schultz AP, Hedden T, Johnson KA, Sperling RA. Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 5200-10. PMID 24719099 DOI: 10.1523/Jneurosci.3579-13.2014 |
0.322 |
|
2014 |
Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, Hyman BT, Locascio JJ, Johnson KA, Sperling RA, Marshall GA, Rentz DM. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1642-51. PMID 24698445 DOI: 10.1016/J.Jagp.2014.02.007 |
0.341 |
|
2014 |
Marshall GA, Lorius N, Locascio JJ, Hyman BT, Rentz DM, Johnson KA, Sperling RA. Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum. Journal of Alzheimer's Disease : Jad. 41: 719-28. PMID 24685624 DOI: 10.3233/Jad-132768 |
0.334 |
|
2014 |
Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, Aisen P. The A4 study: stopping AD before symptoms begin? Science Translational Medicine. 6: 228fs13. PMID 24648338 DOI: 10.1126/Scitranslmed.3007941 |
0.355 |
|
2014 |
Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ, et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Molecular Psychiatry. 19: 1044-51. PMID 24614494 DOI: 10.1038/Mp.2014.9 |
0.331 |
|
2014 |
Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901 |
0.343 |
|
2014 |
Serrano-Pozo A, Qian J, Monsell SE, Blacker D, Gómez-Isla T, Betensky RA, Growdon JH, Johnson KA, Frosch MP, Sperling RA, Hyman BT. Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Annals of Neurology. 75: 597-601. PMID 24585367 DOI: 10.1002/Ana.24125 |
0.331 |
|
2014 |
Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1168-79. PMID 23890751 DOI: 10.1016/j.jagp.2013.03.006 |
0.374 |
|
2014 |
Johnson KA, Mormino E, Rentz DM, Schultz A, Becker JA, Sepulcre J, Chhatwal J, Amariglio R, Papp K, Marshall G, Shoup T, Yokell D, Brady T, Hyman B, Vasdev N, ... Sperling R, et al. DT-01-02: TEMPORAL NEOCORTICAL TAU DEPOSITION MEASURED WITH PET IS ASSOCIATED WITH LONGITUDINAL DECLINE IN MEMORY PERFORMANCE AMONG CLINICALLY NORMAL ELDERLY Alzheimer's & Dementia. 10: P280-P280. DOI: 10.1016/J.Jalz.2014.07.150 |
0.391 |
|
2014 |
Donovan NJ, Hsu D, Dagley A, Schultz A, Amariglio R, Rentz DM, Johnson KA, Sperling RA, Marshall G. P2-154: SUBSYNDROMAL DEPRESSION AND ALZHEIMER'S DISEASE BIOMARKERS IN COGNITIVELY NORMAL ELDERLY Alzheimer's & Dementia. 10: P527-P528. DOI: 10.1016/j.jalz.2014.05.830 |
0.304 |
|
2013 |
Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimer's Research & Therapy. 5: 58. PMID 24257331 DOI: 10.1186/Alzrt222 |
0.335 |
|
2013 |
Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KA. Apathy is associated with increased amyloid burden in mild cognitive impairment. The Journal of Neuropsychiatry and Clinical Neurosciences. 25: 302-7. PMID 24247857 DOI: 10.1176/Appi.Neuropsych.12060156 |
0.336 |
|
2013 |
Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PS. Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. Neuropsychology. 27: 391-401. PMID 23876113 DOI: 10.1037/A0032707 |
0.329 |
|
2013 |
Sepulcre J, Sabuncu MR, Becker A, Sperling R, Johnson KA. In vivo characterization of the early states of the amyloid-beta network. Brain : a Journal of Neurology. 136: 2239-52. PMID 23801740 DOI: 10.1093/Brain/Awt146 |
0.327 |
|
2013 |
Sperling R, Johnson K. Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria. Continuum (Minneapolis, Minn.). 19: 325-38. PMID 23558480 DOI: 10.1212/01.CON.0000429181.60095.99 |
0.338 |
|
2013 |
Carrillo MC, Brashear HR, Logovinsky V, Ryan JM, Feldman HH, Siemers ER, Abushakra S, Hartley DM, Petersen RC, Khachaturian AS, Sperling RA. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 123-131.e1. PMID 23411394 DOI: 10.1016/J.Jalz.2012.12.004 |
0.326 |
|
2013 |
Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S72-83. PMID 23375563 DOI: 10.1016/J.Jalz.2012.10.007 |
0.336 |
|
2013 |
Sperling RA, Karlawish J, Johnson KA. Preclinical Alzheimer disease-the challenges ahead. Nature Reviews. Neurology. 9: 54-8. PMID 23183885 DOI: 10.1038/nrneurol.2012.241 |
0.301 |
|
2013 |
Quiroz YT, Stern CE, Reiman EM, Brickhouse M, Ruiz A, Sperling RA, Lopera F, Dickerson BC. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 556-61. PMID 23134660 DOI: 10.1136/Jnnp-2012-303299 |
0.319 |
|
2013 |
Desikan RS, McEvoy LK, Holland D, Thompson WK, Brewer JB, Aisen PS, Andreassen OA, Hyman BT, Sperling RA, Dale AM. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. Ajnr. American Journal of Neuroradiology. 34: 505-10. PMID 22976236 DOI: 10.3174/Ajnr.A3267 |
0.307 |
|
2013 |
Vannini P, Hedden T, Huijbers W, Ward A, Johnson KA, Sperling RA. The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults. Cerebral Cortex (New York, N.Y. : 1991). 23: 1317-28. PMID 22586140 DOI: 10.1093/Cercor/Bhs108 |
0.331 |
|
2012 |
Marshall GA, Amariglio RE, Sperling RA, Rentz DM. Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease? Neurodegenerative Disease Management. 2: 483-491. PMID 23585777 DOI: 10.2217/nmt.12.55 |
0.373 |
|
2012 |
Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker JA, Buckner RL, Johnson KA, Sperling RA, Rentz DM. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 16233-42. PMID 23152607 DOI: 10.1523/JNEUROSCI.2462-12.2012 |
0.336 |
|
2012 |
Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, ... ... Sperling RA, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/Cli.12.93 |
0.313 |
|
2012 |
Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, Giraldo M, Acosta-Baena N, Sperling RA, Dickerson B, Stern CE, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. The Lancet. Neurology. 11: 1048-56. PMID 23137948 DOI: 10.1016/S1474-4422(12)70228-4 |
0.34 |
|
2012 |
Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, Maye JE, Gidicsin C, Pepin LC, Sperling RA, Johnson KA, Rentz DM. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 50: 2880-6. PMID 22940426 DOI: 10.1016/J.Neuropsychologia.2012.08.011 |
0.359 |
|
2012 |
Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dementia and Geriatric Cognitive Disorders. 34: 96-111. PMID 22922821 DOI: 10.1159/000342119 |
0.344 |
|
2012 |
Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, et al. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology. 79: 1636-44. PMID 22786606 DOI: 10.1212/Wnl.0B013E3182661F74 |
0.368 |
|
2012 |
Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Sperling RA, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753 |
0.321 |
|
2012 |
Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM. Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau. Archives of Neurology. 69: 709-13. PMID 22529247 DOI: 10.1001/Archneurol.2011.3354 |
0.364 |
|
2012 |
Sabuncu MR, Buckner RL, Smoller JW, Lee PH, Fischl B, Sperling RA. The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cerebral Cortex (New York, N.Y. : 1991). 22: 2653-61. PMID 22169231 DOI: 10.1093/Cercor/Bhr348 |
0.315 |
|
2012 |
Vannini P, Hedden T, Becker JA, Sullivan C, Putcha D, Rentz D, Johnson KA, Sperling RA. Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiology of Aging. 33: 1237-52. PMID 21334099 DOI: 10.1016/j.neurobiolaging.2011.01.003 |
0.316 |
|
2012 |
Donovan N, Wadsworth L, Lorius N, Locascio J, Rentz D, Johnson K, Sperling R. P2-236: Regional cortical thinning predicts worsening apathy and hallucinations in mild cognitive impairment and mild Alzheimer's disease dementia Alzheimer's & Dementia. 8: P342-P343. DOI: 10.1016/j.jalz.2012.05.943 |
0.356 |
|
2012 |
Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... Sperling R, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132 |
0.323 |
|
2011 |
Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, et al. Assessment of cognition in early dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e60-e76. PMID 23559893 DOI: 10.1016/J.Jalz.2011.05.001 |
0.349 |
|
2011 |
Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D. Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. The Journal of Clinical Psychiatry. 72: e37. PMID 22244033 DOI: 10.4088/Jcp.10087Tx2C |
0.32 |
|
2011 |
Holtzman DM, Goate A, Kelly J, Sperling R. Mapping the road forward in Alzheimer's disease. Science Translational Medicine. 3: 114ps48. PMID 22190237 DOI: 10.1126/Scitranslmed.3003529 |
0.307 |
|
2011 |
Putcha D, Brickhouse M, O'Keefe K, Sullivan C, Rentz D, Marshall G, Dickerson B, Sperling R. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 17680-8. PMID 22131428 DOI: 10.1523/Jneurosci.4740-11.2011 |
0.382 |
|
2011 |
Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl B. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Archives of Neurology. 68: 1040-8. PMID 21825241 DOI: 10.1001/Archneurol.2011.167 |
0.375 |
|
2011 |
Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, Sperling RA, Johnson KA. Instrumental activities of daily living impairment is associated with increased amyloid burden. Dementia and Geriatric Cognitive Disorders. 31: 443-50. PMID 21778725 DOI: 10.1159/000329543 |
0.337 |
|
2011 |
Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends in Neurosciences. 34: 430-42. PMID 21696834 DOI: 10.1016/J.Tins.2011.05.005 |
0.377 |
|
2011 |
Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 300-8. PMID 21575871 DOI: 10.1016/j.jalz.2010.04.005 |
0.36 |
|
2011 |
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 280-92. PMID 21514248 DOI: 10.1016/J.Jalz.2011.03.003 |
0.377 |
|
2011 |
Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 257-62. PMID 21514247 DOI: 10.1016/J.Jalz.2011.03.004 |
0.323 |
|
2011 |
Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology. 76: 1395-402. PMID 21490323 DOI: 10.1212/Wnl.0B013E3182166E96 |
0.338 |
|
2011 |
Drzezga A, Becker JA, Van Dijk KR, Sreenivasan A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RA. Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain : a Journal of Neurology. 134: 1635-46. PMID 21490054 DOI: 10.1093/brain/awr066 |
0.328 |
|
2011 |
Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA. Amyloid-β associated cortical thinning in clinically normal elderly. Annals of Neurology. 69: 1032-42. PMID 21437929 DOI: 10.1002/Ana.22333 |
0.348 |
|
2011 |
Yang W, Lui RL, Gao JH, Chan TF, Yau ST, Sperling RA, Huang X. Independent component analysis-based classification of Alzheimer's disease MRI data. Journal of Alzheimer's Disease : Jad. 24: 775-83. PMID 21321398 DOI: 10.3233/Jad-2011-101371 |
0.315 |
|
2011 |
Putcha D, O'Keefe K, LaViolette P, O'Brien J, Greve D, Rentz DM, Locascio J, Atri A, Sperling R. Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Human Brain Mapping. 32: 2027-44. PMID 21259385 DOI: 10.1002/Hbm.21166 |
0.301 |
|
2011 |
Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimer's Research & Therapy. 3: 1. PMID 21211070 DOI: 10.1186/Alzrt59 |
0.31 |
|
2011 |
Pihlajamäki M, O'Keefe K, O'Brien J, Blacker D, Sperling RA. Failure of repetition suppression and memory encoding in aging and Alzheimer's disease. Brain Imaging and Behavior. 5: 36-44. PMID 21161449 DOI: 10.1007/s11682-010-9110-3 |
0.308 |
|
2011 |
Marshall G, Lorius N, Locascio J, Rentz D, Johnson K, Sperling R. Low CSF Abeta 1-42 is associated with worsening daily functioning in mild cognitive impairment and mild Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.936 |
0.364 |
|
2011 |
Dickerson B, Albert M, Blacker D, Shah R, DeToledo-Morrell L, Killiany R, Sperling R, Stoub T, Hyman B. O1-07-01: Alzheimer's-signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Alzheimer's & Dementia. 7: S109-S109. DOI: 10.1016/j.jalz.2011.05.272 |
0.34 |
|
2011 |
Dickerson B, Stoub T, Shah R, Sperling R, Killiany R, Albert M, Hyman B, Blacker D, DeToledo-Morrell L. IC-P-040: Alzheimer's signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Alzheimer's & Dementia. 7: S24-S25. DOI: 10.1016/J.Jalz.2011.05.109 |
0.343 |
|
2011 |
Pihlajamäki M, Sperling RA. Functional MRI in Alzheimer's Disease and Other Dementias The Handbook of Alzheimer's Disease and Other Dementias. 535-556. DOI: 10.1002/9781444344110.ch18 |
0.314 |
|
2010 |
Desikan RS, Sabuncu MR, Schmansky NJ, Reuter M, Cabral HJ, Hess CP, Weiner MW, Biffi A, Anderson CD, Rosand J, Salat DH, Kemper TL, Dale AM, Sperling RA, Fischl B, et al. Selective disruption of the cerebral neocortex in Alzheimer's disease. Plos One. 5: e12853. PMID 20886094 DOI: 10.1371/Journal.Pone.0012853 |
0.374 |
|
2010 |
Sperling R, Johnson K. Pro: Can biomarkers be gold standards in Alzheimer's disease? Alzheimer's Research & Therapy. 2: 17. PMID 20587006 DOI: 10.1186/alzrt41 |
0.356 |
|
2010 |
O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RA. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 74: 1969-76. PMID 20463288 DOI: 10.1212/Wnl.0B013E3181E3966E |
0.339 |
|
2010 |
Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, Sperling RA, Johnson KA. Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology. 67: 353-64. PMID 20373347 DOI: 10.1002/ana.21904 |
0.322 |
|
2010 |
Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Medicine. 12: 27-43. PMID 20069392 DOI: 10.1007/S12017-009-8109-7 |
0.341 |
|
2010 |
Pihlajamäki M, O' Keefe K, Bertram L, Tanzi RE, Dickerson BC, Blacker D, Albert MS, Sperling RA. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 28-36. PMID 19571734 DOI: 10.1097/Wad.0B013E3181A785C9 |
0.326 |
|
2009 |
Pihlajamäki M, Sperling RA. Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals. Behavioural Neurology. 21: 77-91. PMID 19847047 DOI: 10.3233/BEN-2009-0231 |
0.349 |
|
2009 |
Dickerson BC, Sperling RA. Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behavioural Neurology. 21: 63-75. PMID 19847046 DOI: 10.3233/BEN-2009-0227 |
0.309 |
|
2009 |
Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 63: 178-88. PMID 19640477 DOI: 10.1016/J.Neuron.2009.07.003 |
0.348 |
|
2009 |
Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cerebral Cortex (New York, N.Y. : 1991). 19: 497-510. PMID 18632739 DOI: 10.1093/Cercor/Bhn113 |
0.302 |
|
2009 |
Sperling R, Johnson K, Pontecorvo MJ, Safirstein B, Farmer M, Holub R, Korn R, Spicer K, Doraiswamy M, Reiman EM, Joshi A, Saha K, Flitter M, Clark CM, Skovronsky DM. P1-084: PET imaging of β-amyloid with florpiramine F18 (18F-AV-45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease Alzheimer's & Dementia. 5: P197-P197. DOI: 10.1016/J.Jalz.2009.04.088 |
0.311 |
|
2008 |
Pihlajamäki M, DePeau KM, Blacker D, Sperling RA. Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 283-92. PMID 18378553 DOI: 10.1097/JGP.0b013e318162a0a9 |
0.302 |
|
2008 |
Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 630-5. PMID 17846109 DOI: 10.1136/jnnp.2007.124149 |
0.315 |
|
2008 |
Pihlajamäki M, Sperling RA. fMRI: Use in early Alzheimer's disease and in clinical trials Future Neurology. 3: 409-421. DOI: 10.2217/14796708.3.4.409 |
0.368 |
|
2007 |
Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Archives of General Psychiatry. 64: 1443-50. PMID 18056553 DOI: 10.1001/Archpsyc.64.12.1443 |
0.36 |
|
2007 |
Rentz DM, Huh TJ, Sardinha LM, Moran EK, Becker JA, Daffner KR, Sperling RA, Johnson KA. Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. Journal of the International Neuropsychological Society : Jins. 13: 821-31. PMID 17697413 DOI: 10.1017/S1355617707071056 |
0.315 |
|
2007 |
Sperling R. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Annals of the New York Academy of Sciences. 1097: 146-55. PMID 17413017 DOI: 10.1196/Annals.1379.009 |
0.404 |
|
2006 |
Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10222-31. PMID 17021177 DOI: 10.1523/Jneurosci.2250-06.2006 |
0.345 |
|
2006 |
Lim Y, Maruff P, Masters CL, Sperling RA, Johnson KA, Mormino BC. P4-118: AV1451 TAU PET, BUT NOT CSF TAU, IS RELATED TO MEMORY DECLINE IN PRECLINICAL AND PRODROMAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1484-P1484. DOI: 10.1016/j.jalz.2018.06.2522 |
0.306 |
|
2006 |
Quiroz YT, Aguero C, Lopera F, Norton DJ, Aguirre-Acevedo DC, Chen K, Baena A, Gatchel JR, Guzman-Velez E, Pardilla-Delgado E, Artola A, Alvarez S, Sperling RA, Reiman EM, Johnson KA. P3-399: ASSOCIATION BETWEEN CORTICAL THINNING AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1253-P1254. DOI: 10.1016/J.Jalz.2018.06.1761 |
0.304 |
|
2006 |
DePeau KM, Pihlajamaki M, Diamond EL, Miller SM, Chua EF, Dickerson BC, Albert MS, Blacker D, Sperling RA. IC-P-086: Failure of hippocampal habituation in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 2: S687-S688. DOI: 10.1016/J.Jalz.2006.05.2291 |
0.318 |
|
2006 |
DePeau KM, Pihlajamaki M, Diamond EL, Miller SM, Chua EF, Dickerson BC, Albert MS, Blacker D, Sperling RA. P2-381: Failure of hippocampal habituation in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 2: S357-S358. DOI: 10.1016/j.jalz.2006.05.1221 |
0.339 |
|
2006 |
Rentz DM, Sardinha LM, Manning LN, Moran EK, Becker JA, Sperling RA, DeKosky ST, Mathis CA, Klunk WE, Fischman AJ, Johnson KA. P2-329: Amyloid burden correlates with cognitive function in normal aging, MCI and AD Alzheimer's & Dementia. 2: S337-S338. DOI: 10.1016/j.jalz.2006.05.1169 |
0.345 |
|
2005 |
Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 65: 404-11. PMID 16087905 DOI: 10.1212/01.Wnl.0000171450.97464.49 |
0.351 |
|
2005 |
Dickerson BC, Sperling RA. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 348-60. PMID 15897955 DOI: 10.1602/neurorx.2.2.348 |
0.314 |
|
2004 |
Rentz DM, Huh TJ, Faust RR, Budson AE, Scinto LF, Sperling RA, Daffner KR. Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology. 18: 38-49. PMID 14744186 DOI: 10.1037/0894-4105.18.1.38 |
0.333 |
|
1996 |
Sandson TA, O'Connor M, Sperling RA, Edelman RR, Warach S. Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology. 47: 1339-42. PMID 8909457 DOI: 10.1212/WNL.47.5.1339 |
0.312 |
|
Show low-probability matches. |